Skip to content

Clinical trials

Recruiting Leukemia, Myeloid, Acute trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Status: Recruiting Country / region: United States Clear all

277 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20071
20092
20111
20121
20131
20144
20152
20163
20174
201813
201914
202010
202118
202227
202322
202445
202556
202652

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting277

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center31
City of Hope Medical Center15
National Cancer Institute (NCI)15
Fred Hutchinson Cancer Center11
Memorial Sloan Kettering Cancer Center10
Masonic Cancer Center, University of Minnesota7
Dana-Farber Cancer Institute6
Massachusetts General Hospital5
OHSU Knight Cancer Institute5
University of Washington5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute277
Myelodysplastic Syndromes101
Precursor Cell Lymphoblastic Leukemia-Lymphoma52
Leukemia32
Hematologic Neoplasms29
Leukemia, Biphenotypic, Acute27
Leukemia, Myelomonocytic, Chronic27
Myeloproliferative Disorders25
Leukemia, Myelogenous, Chronic, BCR-ABL Positive23
Lymphoma, Non-Hodgkin19

Trials

Showing 1 to 25 of 277. Each trial links to its page on Pharma Observatory.

177 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.